K142735

Substantially Equivalent

The Optilite IgG3 kit

Applicant: The Binding Site Group , Ltd.
Product code: CFN
Advisory panel: Immunology
Date received: 2014-09-23
Decision date: 2014-12-21
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Birmingham, GB

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.